Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Profound Medical Corp (NQ: PROF )

10.17 -0.04 (-0.35%)
Streaming Delayed Price Updated: 10:03 AM EST, Nov 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 739
Open 10.06
Bid (Size) 10.04 (3)
Ask (Size) 10.25 (4)
Prev. Close 10.21
Today's Range 10.06 - 10.17
52wk Range 4.500 - 13.82
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Profound Medical to Participate in the Stifel 2023 Healthcare Conference
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical Announces CMS Extension of Temporary ‘Code’ for TULSA to ASC Setting
From Profound Medical Corp.
Via GlobeNewswire

Performance

YTD
-7.92%
-7.92%
1 Month
+25.61%
+25.61%
3 Month
+23.93%
+23.93%
6 Month
-25.30%
-25.30%
1 Year
+117.87%
+117.87%

More News

Read More
Profound Medical Announces Third Quarter 2023 Financial Results
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical: Q1 Earnings Insights
Via Benzinga
Profound Medical to Release Third Quarter 2023 Financial Results on November 2 – Conference Call to Follow
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical 2023 Virtual Analyst & Investor Day Agenda
From Profound Medical Corp.
Via GlobeNewswire
TD SYNNEX, Profound Medical And 3 Stocks To Watch Heading Into Tuesday
Via Benzinga
Earnings Preview For Profound Medical
Via Benzinga
Profound Medical Receives U.S. FDA 510(k) Clearance for TULSA-PRO® Thermal Boost
From Profound Medical Corp.
Via GlobeNewswire
Save the Date: Profound Medical to Host Virtual Analyst & Investor Day on October 13
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical to Participate in the 2023 Cantor Global Healthcare Conference
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical Announces At-the-Market Offering of up to US$30,000,000
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical Announces Second Quarter 2023 Financial Results
From Profound Medical Corp.
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2023
Via Benzinga
Profound Medical to Release Second Quarter 2023 Financial Results on August 9 – Conference Call to Follow
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical Announces New CPT® Category 1 Codes from the AMA for TULSA to Treat Prostate Diseases
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical Announces Upcoming Investor Events
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical to Participate in A.G.P.’s Virtual Healthcare Conference
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical Annual and Special Meeting of Shareholders Voting Results
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical Announces First Quarter 2023 Financial Results
From Profound Medical Corp.
Via GlobeNewswire
TULSA Procedure Featured in the Scientific Program at the American Urological Association 2023 Annual Meeting
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical to Release First Quarter 2023 Financial Results on May 10 – Conference Call to Follow
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical to to Participate in the 2023 Bloom Burton & Co. Healthcare Investor Conference
From Profound Medical Corp.
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For March 21, 2023
Via Benzinga
Profound Medical Announces Fourth Quarter and Full Year 2022 Financial Results
From Profound Medical Corp.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.